Clinical trial Recruiting at 3 sites Observational Ages 18 and up

Confirming the GLOW800 microscope accessory's performance with the ARveo8X surgical microscope.

Official title: Fluorescence Visualization and Image Quality Evaluation of Digital Visualization During Standard of Care Procedure in the Cerebral Vascular Area as Well as Blood Flow During Plastic and Reconstructive Surgery (PRS) (Leica GLOW800)

Run by Leica Microsystems (Schweiz) AG · NCT07164040 · Data updated 2026-11-12

This project tests whether the GLOW800 microscope accessory helps surgeons see blood flow and improves image quality during adult cerebral vascular and plastic/reconstructive surgeries.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment31 (estimated)
SponsorLeica Microsystems (Schweiz) AG
Industry-sponsored
Locations3 sites (Porto and 2 other locations)
StatusRecruiting
StartedJanuary 8, 2026
Main results expectedNovember 30, 2026
Study endsJuly 30, 2027
Registry record updatedNovember 2, 2026
Trial IDNCT07164040 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) scheduled for cerebral vascular or plastic/reconstructive surgery where ICG will be used and who can give informed consent are ideal candidates.

Probably not a fit

Patients who are pediatric, who will not receive ICG, or who have known contraindications or allergy to ICG are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This post-market clinical follow-up is an observational, non-interventional study collecting routine-care data on the CE‑marked GLOW800 microscope accessory used with the ARveo8X microscope. The device overlays Indocyanine Green (ICG) fluorescence onto the anatomical view in real time to improve visualization of blood flow without switching views. Up to 31 adult patients undergoing cerebral vascular or plastic and reconstructive surgery will be enrolled across several European sites, with no additional invasive procedures beyond standard care. Primary endpoints are fluorescence visibility and image quality as rated by surgeons, with secondary monitoring of device safety using structured questionnaires and microscope video recordings.

Why it matters

Potential benefit: If successful, the device could help surgeons make quicker, more confident decisions by improving intraoperative visualization of blood flow and streamlining workflow.

How similar studies have gone: ICG fluorescence imaging and overlay technologies have been used in other surgical settings and reported improved visualization, and the GLOW800 is CE‑marked though this PMCF collects additional real‑world confirmation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Candidates for the study must be appropriate patients for surgical interventions in the cerebral vascular area or for plastic and reconstructive surgery and have to fulfil all of the following inclusion criteria to be eligible for the recruitment of the study.

1. Participants must be 18 years of age or older at the time of signing the informed consent.
2. Participants must have a condition requiring surgical intervention in the cerebral vascular area as well as during plastic and reconstructive surgery.
3. The Indocyanine Green (ICG) cyanine dye is administered as a contrast agent per instructions for use.
4. The participant or their legal representative must understand the study and have voluntarily signed and dated the Informed Consent Form, which has been approved by the Sponsor and the Ethics Committee for this study

Exclusion Criteria:

Candidates who meet any of the following exclusion criteria will not be eligible for recruitment in the study.

1. Known allergy to Indocyanine Green (ICG) cyanine dye.
2. Any uncontrolled systemic condition that may adversely affect the surgical outcome.
3. Patients holding United States citizenship.
4. Severe iodine-induced reactions to macromolecular iodine-containing compounds (e.g., iodinated contrast media, iodine-based antiseptics, or drugs like amiodarone), especially if the reaction involved anaphylaxis or respiratory compromise.

Where it's running

  • Unidade Local de Saúde de São João
    Porto, Portugal
    Recruiting
  • Hospital Germans Trias I Pujol
    Barcelona, Spain
    Recruiting
  • University Hospital Basel
    Basel, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.